Photo via Reuters.
(New York, New York) – Podcast host Joe Rogan says he shared information with President Donald Trump about ibogaine, a controversial psychedelic being studied for addiction treatment. According to Rogan, Trump responded quickly in a private exchange and appeared open to accelerating federal review of such therapies.
Ibogaine remains illegal in the U.S. and is not approved by the FDA, though researchers have explored its potential in treating opioid dependence and other substance use disorders. Any effort to fast-track approval would face significant regulatory hurdles, including clinical trials and safety evaluations.
The claim has not been independently confirmed by the administration, and no formal policy shift has been announced.
